Tony, I keep coming back to the summation of Phylogica's current collaborations which is disclosed in the Edison Report; "review of milestone achievements [under Roche collaboration] in progress (undisclosed milestone now due)".
Further: "The potential exercise of Pfizer or Roche's options to license the peptides generated under their respective deals would represent the next milestone payments from these partners following conclusion of the ongoing evaluation stage."
If we take a literal interpretation of the Edison Report and assume its report is factual, then a major validation is at hand.
It could be Ben even though BEN_5000 sounds more like a HotCopper user name than our first licensed phylomer peptide.
Regards,
Wayne.
PYC Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)